Williams Donald Allen — SEC Form 4 filings
SEC reporting owner CIK 1620013. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-01 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 21,000 shares, $28,669 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 5,000 shares @ $1.88 ($9,400) in PALISADE BIO, INC., filed 2026-01-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PALISADE BIO, INC. (PALI) | Director | 11 | 4 legs · 21,000 sh · $28,669 | — | 9 |
| Forte Biosciences, Inc. (FBRX) | Director | 1 | — | — | 1 |
Form 4 filings — Williams Donald Allen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | PALISADE BIO, INC. (PALI) | Grant/award (A): 1,498,900 · Option exercise (M): 60,666 · Option exercise (M): 60,666 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | PALISADE BIO, INC. (PALI) | Purchase (P): 5,000 @ $1.67 | EDGAR |
| 2026-01-13 | 4 | PALISADE BIO, INC. (PALI) | Purchase (P): 5,000 @ $1.88 | EDGAR |
| 2025-11-06 | 4/A | PALISADE BIO, INC. (PALI) | Grant/award (A): 182,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | PALISADE BIO, INC. (PALI) | Grant/award (A): 1,538,700 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | PALISADE BIO, INC. (PALI) | Grant/award (A): 64,400 (derivative) @ $0 | EDGAR |
| 2024-11-22 | 4 | PALISADE BIO, INC. (PALI) | Option exercise (M): 388 @ $0 | EDGAR |
| 2024-08-22 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | PALISADE BIO, INC. (PALI) | Grant/award (A): 2,100 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | PALISADE BIO, INC. (PALI) | Option exercise (M): 340 @ $0 | EDGAR |
| 2024-05-29 | 4 | PALISADE BIO, INC. (PALI) | Purchase (P): 1,000 @ $4.86 | EDGAR |
| 2024-02-01 | 4 | PALISADE BIO, INC. (PALI) | Purchase (P): 10,000 @ $0.60 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1620013 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →